Sergey I Luyksaar

5PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersEnvironmental biotechnology diagnostics (incl. biosensors)Cheminformatics and quantitative structure-activity relationshipsMedical bacteriologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 23, 2024
Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses.

Elizaveta S Darnotuk, Andrei E Siniavin, Natal'ya S Shastina

|Mar 16, 2023
Fluorothiazinon inhibits the virulence factors of uropathogenic Escherichia coli involved in the development of urinary tract infection.

E A Koroleva, A V Soloveva, E Y Morgunova

|Sep 09, 2022
Antiviral Activity of N1,N3-Disubstituted Uracil Derivatives against SARS-CoV-2 Variants of Concern.

Andrei E Siniavin, Mikhail S Novikov, Vladimir A Gushchin

|Jan 22, 2022
Preventative treatment with Fluorothiazinon suppressed Acinetobacter baumannii-associated septicemia in mice.

Nataliya E Bondareva, Anna V Soloveva, Anna B Sheremet

|Oct 03, 2018
Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Pseudomonas aeruginosa Infection in Mice.

Anna B Sheremet, Naylia A Zigangirova, Egor S Zayakin

Pageof 1

Frequent Collaborators

2 joint publications

Nataliya E Bondareva

2 joint publications

Andrei E Siniavin

1 joint publications

Egor S Zayakin

1 joint publications

Natalie V Kobets